nn
" The Voice Of Interventional Pain Management "

celebrating our 10th anniversary
 

Oct. 31, 2012

 

  1. Why Doctors Prescribe Opioids to Known Opioid Abusers
  2. Meningitis: New Drug Recall, 29 Dead
  3. Second Mass. Compounding Pharmacy Surrenders License
  4. Meningitis Outbreak Tests Physician Trust in Compounding Pharmacies
  5. Opinion: Advertising the Truth about Who's a Physician
  6. Organized Medicine Unveils Plan to Overhaul Medicare Delivery
  7. How ACA repeal, GOP Medicaid block grant plan could save $1.7T
  8. Course Videos Available for Evolution of Responsible Opioid Prescribing: Good, Bad, and Ugly
  9. Questions Linger on Medicaid Pay Hike
  10. FDA Approves Pain Treatment for Cancer Patients
  11. State Society News
  12. Physician Wanted  

whyWhy Doctors Prescribe Opioids to Known Opioid Abusers

 

Prescription opioid abuse is an epidemic in the United States. In 2010, there were reportedly as many as 2.4 million opioid abusers in this country, and the number of new abusers had increased by 225% between 1992 and 2000.1 Sixty percent of the opioids that are abused are obtained directly or indirectly through a physician's prescription. In many instances, doctors are fully aware that their patients are abusing these medications or diverting them to others for nonmedical use, but they prescribe them anyway. Why? Recent changes in medicine's philosophy of pain treatment, cultural trends in Americans' attitudes toward suffering, and financial disincentives for treating addiction have contributed to this problem.

 

NEJM

 

deadMeningitis: New Drug Recall, 29 Dead

 

A sister company of the compounding pharmacy at the heart of the fungal meningitis outbreak that has now claimed 29 lives is voluntarily recalling all its products.

The move is an "expansion of our cooperation" with the FDA and the Massachusetts Board of Registration in Pharmacy, Ameridose, of Westborough, Mass., said in a statement today.

 

The company, which shares ownership with the New England Compounding Center, said it does not know of any adverse reactions from its products and there has been no evidence of impurities. Instead, the company said, the move is being undertaken out of of an "abundance of caution."

 

 

MedPage Today

 

secondSecond Mass. Compounding Pharmacy Surrenders License

 

A second Massachusetts compounding pharmacy surrendered its license after state inspectors found "significant" issues that could affect sterility, state health officials said.

 

The pharmacy, Infusion Resource, was also found to have a center for giving intravenous medications to patients in violation of state regulations, which require a clinic license, Dr. Madeleine Biondolillo, director of the Massachusetts Department of Public Health Bureau of Healthcare Safety and Quality, said Sunday.

 

 

CNN Health

 

testsMeningitis Outbreak Tests Physician Trust in Compounding Pharmacies

 

Michael F. Schafer, MD, a Chicago orthopedic surgeon, gives about 100 epidural steroid injections a year to help relieve back pain caused by conditions such as a herniated disk. So he was taken aback when news surfaced of a deadly fungal meningitis outbreak traced to steroids produced by a compounding pharmacy.

 

Dr. Schafer checked the source of the steroids he uses and found that they did not come from the drug compounder in question, Framingham, Mass.-based New England Compounding Center. His hospital, Northwestern Memorial, ordered the injectable methylprednisolone acetate from Pfizer Inc., which markets the drug as Depo-Medrol and has had no reported sterility lapses.

 

 

AMA news

 

 

opinionOpinion: Advertising the Truth about Who's a Physician

 

One can hardly fault patients for feeling confused - and more than a little cheated.

A billboard advertises the house call services of a nurse practitioner by using the abbreviation "Dr." before her name. A nonphysician introduces himself to a patient as a doctor because he has a PhD in a field completely outside of medicine. Patients are discharged from the hospital with follow-up care instructions for their primary care physicians, only to find out at that point that the doctors aren't really doctors at all.

 

These are some of the documented examples of midlevel health professionals and other nonphysicians misrepresenting themselves to patients, either directly or indirectly. They also are compelling reasons why a dozen states have enacted legislation prohibiting such misrepresentation. Now the rest of the states need to follow their leads.

 

AMA news

unveilOrganized Medicine Unveils Plan to Overhaul Medicare Delivery

 

Washington More beneficiary choices, infrastructure investments and payments that reflect the costs to physicians of providing services are the major principles the physician community will use as guideposts as lawmakers look to transition to a new Medicare delivery system. That's what the American Medical Association and other organized medicine groups stated in an Oct. 15 letter to Congress.

 

The national and state medical and specialty societies identified the core elements they will support to move from the one-size-fits-all Medicare fee-for-service system to one offering an array of options to seniors and physicians. The organizations also reaffirmed their support for a repeal of the sustainable growth rate formula used to help calculate Medicare physician pay rates. Congress has prevented SGR cuts temporarily for the past decade, but physicians say the uncertainty created by the unstable pay system has hurt practices and prevented improvements in health care delivery.

 

 

AMA news

howHow ACA repeal, GOP Medicaid block grant plan could save $1.7T

 

The House Republican plan to repeal President Barack Obama's health law and turn Medicaid into a block grant program would save the federal government $1.7 trillion from 2013 to 2022, a 38-percent spending reduction, according to a recent report by the Urban Institute for the Kaiser Family Foundation.

 

It would also result in 31 million to 38 million fewer people getting Medicaid coverage in 2022, according to the report. The entitlement program, which is jointly financed by the state and federal governments, now provides health coverage to about 62 million poor people, about half of whom are children.

 

 

Healthcare Finance news

 

courseCourse Videos Available for Evolution of Responsible Opioid Prescribing: Good, Bad, and Ugly


The Kentucky Society of Interventional Pain Physicians designed this 1.5 day conference for physicians, nurses, and other medical personnel involved.

 

Order the online videos and receive 1.5 days of course video via the Internet. You can watch them on your computer or any computer with Internet access. You will be given a password to access the high quality streaming video of each day.
 

Designed to learn more about KASPER, the Pill Mill law, pain management facility, guidance on using controlled substances, adherence monitoring, documentation, and various board regulations.

 



 Participants in the Evolution of Responsible Opioid Prescribing: Good, Bad, and Ugly Course should be able to apply the fundamental concepts of managing controlled substances in your practice, from pharmacology and the clinical uses to identifying abuse and the legal aspects of prescribing, for better outcomes and reduced side effects.

 

To order course videos:

http://www.asipp.org/Education/KSIPP/orderform-ksipp.html

lingerQuestions Linger on Medicaid Pay Hike

 

To recruit more doctors to treat the poor, President Barack Obama's health law took a simple approach: temporarily pay doctors more money.

 

Starting Jan. 1, primary care doctors when treating patients on Medicaid, the state-federal health insurance program for the poor, will get the same rates they are paid when caring for seniors in the Medicare program. The higher rates will last for 2 years.

 

 

MedPage Today

fdaFDA Approves Pain Treatment for Cancer Patients

 

The Food and Drug Administration has approved the ExAblate MRI-guided focused ultrasound therapy to treat patients with pain from bone metastases.

The treatment, from InSightec, is designed to treat patients who are unable to undergo radiation treatment for their pain. It is a non-invasive, outpatient therapy and was approved for use in uterine fibroids patients in 2004.

 

 Becker's ASC Review

 

 

 


All contents Copyright © 2008
American Society of Interventional Pain Physicians ®
81 Lakeview Drive, Paducah, KY 42001
Phone 270.554.9412, Fax 270.554.5394
E-mail asipp@asipp.org